NYSE:DVA DaVita (DVA) Stock Price, News & Analysis $137.32 -5.18 (-3.64%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$136.30▼$144.0550-Day Range$132.25▼$147.1452-Week Range$71.51▼$147.93Volume830,982 shsAverage Volume577,431 shsMarket Capitalization$12.04 billionP/E Ratio15.60Dividend YieldN/APrice Target$146.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get DaVita alerts: Email Address DaVita MarketRank™ Stock AnalysisAnalyst RatingHold2.25 Rating ScoreUpside/Downside6.3% Upside$146.00 Price TargetShort InterestBearish5.77% of Float Sold ShortDividend StrengthN/ASustainability-1.06Upright™ Environmental ScoreNews Sentiment0.72Based on 18 Articles This WeekInsider TradingSelling Shares$698,214 Sold Last QuarterProj. Earnings Growth6.96%From $9.62 to $10.29 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.33 out of 5 starsMedical Sector368th out of 936 stocksMiscellaneous Health & Allied Services, Not Elsewhere Classified Industry3rd out of 9 stocks 1.1 Analyst's Opinion Consensus RatingDaVita has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageDaVita has only been the subject of 3 research reports in the past 90 days.Read more about DaVita's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.77% of the float of DaVita has been sold short.Short Interest Ratio / Days to CoverDaVita has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in DaVita has recently increased by 2.89%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldDaVita does not currently pay a dividend.Dividend GrowthDaVita does not have a long track record of dividend growth. Previous Next 4.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreDaVita has received a 68.98% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "In-center hemodialysis services", "Peritoneal dialysis services", and "Home hemodialysis services" products. See details.Environmental SustainabilityThe Environmental Impact score for DaVita is -1.06. Previous Next 3.7 News and Social Media Coverage News SentimentDaVita has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for DaVita this week, compared to 7 articles on an average week.Search Interest9 people have searched for DVA on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows7 people have added DaVita to their MarketBeat watchlist in the last 30 days. This is an increase of 17% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, DaVita insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $698,214.00 in company stock.Percentage Held by InsidersOnly 2.00% of the stock of DaVita is held by insiders.Percentage Held by Institutions90.12% of the stock of DaVita is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DaVita's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for DaVita are expected to grow by 6.96% in the coming year, from $9.62 to $10.29 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DaVita is 15.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.05.Price to Earnings Ratio vs. SectorThe P/E ratio of DaVita is 15.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.27.Price to Earnings Growth RatioDaVita has a PEG Ratio of 1.10. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDaVita has a P/B Ratio of 10.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about DaVita's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About DaVita Stock (NYSE:DVA)DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Read More DVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DVA Stock News HeadlinesJuly 27 at 1:14 AM | americanbankingnews.comAnalysts Set DaVita Inc. (NYSE:DVA) Target Price at $144.67July 25 at 9:07 AM | msn.comDaVita HealthCare (DVA) Gains As Market Dips: What You Should KnowJuly 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…July 25 at 6:20 AM | americanbankingnews.comDaVita (NYSE:DVA) Price Target Raised to $150.00 at TD CowenJuly 24 at 6:45 PM | markets.businessinsider.comBalanced Outlook: Hold Rating on DaVita Amid Valuation and Regulatory UncertaintiesJuly 22, 2024 | nz.finance.yahoo.comDaVita Inc. (DVA.MX)July 22, 2024 | msn.comDaVita HealthCare (DVA) Laps the Stock Market: Here's WhyJuly 19, 2024 | msn.comFinancial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False ClaimsJuly 27, 2024 | Crypto 101 Media (Ad)Next opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…July 18, 2024 | prnewswire.comDaVita Inc. Schedules 2nd Quarter 2024 Investor Conference CallJuly 16, 2024 | globenewswire.comRenal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits ResearchJuly 13, 2024 | reuters.comUS FTC probing DaVita, Fresenius Medical, Politico reportsJune 15, 2024 | fool.com2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to AvoidJune 11, 2024 | investorplace.comBuffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire HathawayJune 11, 2024 | benzinga.comDaVita, Nuwellis Extend Pilot Collaboration for AquadexJune 7, 2024 | fool.comThese Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?May 31, 2024 | seekingalpha.comDaVita: A Stellar Run With EPS Upside Likely Ahead, Downgrading On ValuationMay 23, 2024 | finance.yahoo.comA Look At The Intrinsic Value Of DaVita Inc. (NYSE:DVA)See More Headlines Receive DVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DaVita and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealth Care Services Current SymbolNYSE:DVA CUSIP23918K10 CIK927066 Webwww.davita.com Phone(720) 631-2100Fax302-636-5454Employees70,000Year Founded1999Price Target and Rating Average Stock Price Target$146.00 High Stock Price Target$150.00 Low Stock Price Target$134.00 Potential Upside/Downside+6.3%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$8.80 Trailing P/E Ratio15.61 Forward P/E Ratio14.28 P/E Growth1.1Net Income$691.53 million Net Margins6.61% Pretax Margin10.81% Return on Equity68.52% Return on Assets4.98% Debt Debt-to-Equity Ratio7.95 Current Ratio1.43 Quick Ratio1.37 Sales & Book Value Annual Sales$12.14 billion Price / Sales0.99 Cash Flow$16.05 per share Price / Cash Flow8.56 Book Value$13.63 per share Price / Book10.08Miscellaneous Outstanding Shares87,700,000Free Float85,946,000Market Cap$12.05 billion OptionableOptionable Beta0.87 Social Links (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Javier J. Rodriguez (Age 53)CEO & Executive Director Comp: $2.98MMr. Joel Ackerman (Age 59)CFO & Treasurer Comp: $1.19MMs. Kathleen Alyce Waters (Age 56)Chief Legal & Public Affairs Officer Comp: $1.08MMr. James O. Hearty (Age 55)Chief Compliance Officer Comp: $768.29kMr. Michael David Staffieri (Age 50)Chief Operating Officer of Kidney Care Comp: $1.65MMr. Christopher Michael Berry (Age 49)Group VP & Chief Accounting Officer Mr. Jim GustafsonVice President of Investor RelationsMr. Kenneth Gardner Smith (Age 43)Chief People Officer Mr. Misha PalecekChief Transformation Officer of U.S. Kidney Care BusinessDr. Jeffrey Allen GiullianChief Medical Officer of Kidney CareMore ExecutivesKey CompetitorsLaboratory Co. of AmericaNYSE:LHQuest DiagnosticsNYSE:DGXChemedNYSE:CHER1 RCMNASDAQ:RCMCorVelNASDAQ:CRVLView All CompetitorsInsiders & InstitutionsKintegral Advisory LLCBought 3,105 shares on 7/27/2024Ownership: 0.009%Bank of New York Mellon CorpSold 2,382 shares on 7/26/2024Ownership: 0.509%State of Michigan Retirement SystemSold 700 shares on 7/26/2024Ownership: 0.017%Allspring Global Investments Holdings LLCSold 37,105 shares on 7/26/2024Ownership: 0.003%AlphaCentric Advisors LLCBought 623 shares on 7/26/2024Ownership: 0.002%View All Insider TransactionsView All Institutional Transactions DVA Stock Analysis - Frequently Asked Questions How have DVA shares performed this year? DaVita's stock was trading at $104.76 at the beginning of 2024. Since then, DVA stock has increased by 31.1% and is now trading at $137.32. View the best growth stocks for 2024 here. How were DaVita's earnings last quarter? DaVita Inc. (NYSE:DVA) issued its quarterly earnings results on Thursday, May, 2nd. The company reported $2.38 EPS for the quarter, topping analysts' consensus estimates of $1.95 by $0.43. The business's revenue was up 6.9% on a year-over-year basis. Read the conference call transcript. What is Javier Rodriguez's approval rating as DaVita's CEO? 289 employees have rated DaVita Chief Executive Officer Javier Rodriguez on Glassdoor.com. Javier Rodriguez has an approval rating of 77% among the company's employees. Does DaVita have any subsidiaries? DaVita subsidiaries include Northwest Physicians Network, Purity Dialysis, Family Health Care of Central Florida, Healthcare Partners, Gambro Healthcare, Aberdeen Dialysis LLC, Accountable Kidney Care LLC, and others. Who are DaVita's major shareholders? Top institutional investors of DaVita include Bank of New York Mellon Corp (0.51%), Wedge Capital Management L L P NC (0.31%), Sumitomo Mitsui Trust Holdings Inc. (0.14%) and Railway Pension Investments Ltd (0.10%). Insiders that own company stock include Javier Rodriguez, Kathleen Alyce Waters, Michael David Staffieri, Joel Ackerman, James O Hearty, Charles Berg, John M Nehra, Phyllis R Yale, Barbara J Desoer, Pamela M Arway and Paula A Price. View institutional ownership trends. How do I buy shares of DaVita? Shares of DVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of DaVita own? Based on aggregate information from My MarketBeat watchlists, some other companies that DaVita investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Micron Technology (MU), Aegean Marine Petroleum Network (ANW) and AT&T (T). This page (NYSE:DVA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
